Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
ChinaIPO:
Website:
http://www.ftzy.com.cnNext earnings report:
29 November 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 15 Nov 2024 14:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
PTHL Latest News
BEIJING, China, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company” or “Pheton”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced the closing of its initial public offering (the “Offering”) of 2,250,000 Class A ordinary shares at a public offering price of $4.00 per share, for total gross proceeds of $9 million, before deducting underwriting discounts and other related expenses.
BEIJING, China, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company” or “Pheton”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced the pricing of its initial public offering (the “Offering”) of 2,250,000 Class A ordinary shares at a public offering price of $4.00 per Class A ordinary share, for total gross proceeds of $9 million, before deducting underwriting discounts and other related expenses. In addition, Pheton has granted the underwriters a 45-day option to purchase up to an additional 337,500 Class A ordinary shares at the public offering price, less underwriting discounts. The shares are expected to begin trading on the Nasdaq Capital Market on September 5, 2024, under the ticker symbol “PTHL.” The offering is expected to close on September 6, 2024, subject to satisfaction of customary closing conditions.
What type of business is Pheton Holdings Ltd Class A Ordinary Shares?
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.
What sector is Pheton Holdings Ltd Class A Ordinary Shares in?
Pheton Holdings Ltd Class A Ordinary Shares is in the Healthcare sector
What industry is Pheton Holdings Ltd Class A Ordinary Shares in?
Pheton Holdings Ltd Class A Ordinary Shares is in the Medical Devices industry
What country is Pheton Holdings Ltd Class A Ordinary Shares from?
Pheton Holdings Ltd Class A Ordinary Shares is headquartered in China
What is Pheton Holdings Ltd Class A Ordinary Shares website?
https://www.ftzy.com.cn
Is Pheton Holdings Ltd Class A Ordinary Shares in the S&P 500?
No, Pheton Holdings Ltd Class A Ordinary Shares is not included in the S&P 500 index
Is Pheton Holdings Ltd Class A Ordinary Shares in the NASDAQ 100?
No, Pheton Holdings Ltd Class A Ordinary Shares is not included in the NASDAQ 100 index
Is Pheton Holdings Ltd Class A Ordinary Shares in the Dow Jones?
No, Pheton Holdings Ltd Class A Ordinary Shares is not included in the Dow Jones index
When was Pheton Holdings Ltd Class A Ordinary Shares the previous earnings report?
No data
When does Pheton Holdings Ltd Class A Ordinary Shares earnings report?
The next expected earnings date for Pheton Holdings Ltd Class A Ordinary Shares is 29 November 2024